In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease
Sign Up to like & getrecommendations! Published in 2018 at "Brain"
DOI: 10.1093/brain/awx310
Abstract: See Gratwicke and Foltynie (doi:10.1093/brain/awx333) for a scientific commentary on this article. Cognitive impairments in Parkinson’s disease show variable onset, severity and progression. Ray et al. demonstrate that the future cognitive status of newly diagnosed… read more here.
Keywords: disease; vivo cholinergic; parkinson disease; cognitive decline ... See more keywords